Cyclosporine Treatment of Inflammatory Bowel Disease
Open Access
- 31 October 1992
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 67 (10) , 981-990
- https://doi.org/10.1016/s0025-6196(12)60930-6
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease.Gut, 1992
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin ANature, 1991
- Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.Gut, 1990
- Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin.Gut, 1990
- T-cell activation in Crohn's diseaseGastroenterology, 1990
- CyclosporineNew England Journal of Medicine, 1989
- REGULATION OF GENE EXPRESSION IN LECTIN-STIMULATED OR LYMPHOKINE-STIMULATED T LYMPHOCYTES1Transplantation, 1988
- Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colonGastroenterology, 1987
- Clinical Pharmacokinetics of CyclosporinClinical Pharmacokinetics, 1986